Global Sustained Release Excipients Market Forecasted to Reach USD 3.45 Billion by 2035 with 8.1% Annual Growth

The global sustained release excipients market is projected to reach USD 1.58 billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2035, ultimately reaching a value of USD 3.45 billion by 2035.

The sustained release excipients market forms a crucial component of the pharmaceutical industry, supporting the development of drug formulations that release active ingredients gradually over time. These excipients are essential in modifying the drug release rate, ensuring consistent therapeutic effects, reducing dosage frequency, and improving patient compliance. Used in a variety of dosage forms-especially oral tablets and capsules-sustained release excipients enable the controlled delivery of medications over an extended period. This not only enhances efficacy but also minimizes potential side effects. With growing interest in advanced drug delivery systems, the demand for effective and reliable excipients has gained significant momentum, making them indispensable in modern pharmaceutical formulations.

Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=7994

Market Insights

Delving deeper into the market, several key factors shape its landscape. Sustained release excipients are often categorized into polymers (natural and synthetic), lipids, and other carriers that influence the release profile of the drug. Hydrophilic matrix formers, hydrophobic agents, and coating materials are some commonly used substances. Pharmaceutical companies are increasingly focusing on customizing release profiles based on therapeutic needs, patient demographics, and treatment timelines. Furthermore, the rise of chronic diseases such as diabetes, cardiovascular conditions, and neurological disorders has driven the need for long-acting medications, indirectly fueling demand for sustained release technologies. Another insight is the growing shift toward combination therapies where excipients play a pivotal role in balancing the release of multiple active ingredients within a single dosage.

Market Growth

The sustained release excipients market is witnessing steady and consistent growth worldwide. Several factors contribute to this trajectory, including the expansion of pharmaceutical manufacturing capabilities, the rising number of approved sustained release drugs, and increasing investment in drug delivery innovation. Developed regions are leading in terms of technological advancement, while emerging economies are catching up rapidly due to growing healthcare awareness and improved access to medications. The trend toward patient-centric treatment regimens-especially for chronic conditions-further supports the growth of this market. Additionally, the increasing preference for oral solid dosage forms over injectables is another contributing factor, as these formulations are easier to administer and more acceptable to patients across age groups.

List of Key Companies Profiled in The Report

BASF
International Flavors & Fragrances, Inc.
Ashland Global
Evonik Industries
Croda International Plc
Gattefossé
Merck KGaA
Others

Recent Industry News

In recent industry updates, several pharmaceutical companies have announced collaborations with excipient manufacturers to co-create next-generation sustained release formulations. These partnerships aim to optimize drug efficacy, patient experience, and product shelf life. Some companies are expanding their excipient product lines by launching new grades of polymers specifically engineered for controlled release applications. Industry events and expos have also highlighted sustained release technologies as a key area of innovation, bringing together formulators and excipient developers under one roof. Another noteworthy development is the focus on regulatory alignment, with manufacturers working toward certifications and compliance that ensure excipients meet the evolving standards of global drug authorities. These updates reflect an industry that's not only growing but also actively refining its practices to stay ahead.

Notable Developments

Several notable developments have taken place in this market, particularly around material science and formulation technology. Advances in polymer science have led to the introduction of new excipients that offer greater control over drug release kinetics. These materials are more efficient, require smaller dosages, and support simpler manufacturing processes. Companies are also exploring hybrid excipients-materials that combine the properties of multiple functional ingredients to achieve better stability and performance. Another area of innovation is the use of excipients that respond to environmental triggers like pH or temperature, allowing for site-specific drug release in the body. Additionally, sustained release excipients are being tailored for use with highly potent or poorly soluble drugs, solving challenges related to bioavailability and safety. These innovations highlight how excipient technology is not just supporting but actively advancing the capabilities of modern drug delivery.

Want Full Report? Enquire Here-https://www.factmr.com/report/sustained-release-excipients-market

Competitive Outlook

The Sustained Release Excipients Market is marked by strong competition among excipient manufacturers, drug formulation experts, and chemical innovators. Mid-tier players like Gattefossé, Merck KGaA, and Valeant focus on lipid and polymer-based technologies, offering solutions such as biodegradable polymers and hydrophilic matrices for precise drug release.

Companies like Pfizer and Sun Pharma leverage their strengths in finished drug formulations to expand proprietary excipient use, investing in R&D for nanotechnology and extended-release coatings.

Meanwhile, leaders such as Ashland Global and Evonik Industries are advancing intelligent excipient systems, incorporating AI-driven formulation and polymeric drug carriers to support extended-release solutions across diverse therapeutic areas.

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR:

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.